Patient Characteristics and General Practitioners' Advice to Stop Statins in Oldest-Old Patients: a Survey Study Across 30 Countries
- PMID: 30652277
- PMCID: PMC6711940
- DOI: 10.1007/s11606-018-4795-x
Patient Characteristics and General Practitioners' Advice to Stop Statins in Oldest-Old Patients: a Survey Study Across 30 Countries
Abstract
Background: Statins are widely used to prevent cardiovascular disease (CVD). With advancing age, the risks of statins might outweigh the potential benefits. It is unclear which factors influence general practitioners' (GPs) advice to stop statins in oldest-old patients.
Objective: To investigate the influence of a history of CVD, statin-related side effects, frailty and short life expectancy, on GPs' advice to stop statins in oldest-old patients.
Design: We invited GPs to participate in this case-based survey. GPs were presented with 8 case vignettes describing patients > 80 years using a statin, and asked whether they would advise stopping statin treatment.
Main measures: Cases varied in history of CVD, statin-related side effects and frailty, with and without shortened life expectancy (< 1 year) in the context of metastatic, non-curable cancer. Odds ratios adjusted for GP characteristics (ORadj) were calculated for GPs' advice to stop.
Key results: Two thousand two hundred fifty GPs from 30 countries participated (median response rate 36%). Overall, GPs advised stopping statin treatment in 46% (95%CI 45-47) of the case vignettes; with shortened life expectancy, this proportion increased to 90% (95CI% 89-90). Advice to stop was more frequent in case vignettes without CVD compared to those with CVD (ORadj 13.8, 95%CI 12.6-15.1), with side effects compared to without ORadj 1.62 (95%CI 1.5-1.7) and with frailty (ORadj 4.1, 95%CI 3.8-4.4) compared to without. Shortened life expectancy increased advice to stop (ORadj 50.7, 95%CI 45.5-56.4) and was the strongest predictor for GP advice to stop, ranging across countries from 30% (95%CI 19-42) to 98% (95% CI 96-99).
Conclusions: The absence of CVD, the presence of statin-related side effects, and frailty were all independently associated with GPs' advice to stop statins in patients aged > 80 years. Overall, and within all countries, cancer-related short life expectancy was the strongest independent predictor of GPs' advice to stop statins.
Keywords: cardiovascular diseases; clinical decision-making; drug therapy; general practitioners; hydroxymethylglutaryl-CoA reductase inhibitors; palliative care.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures

Similar articles
-
Burden of cardiovascular disease across 29 countries and GPs' decision to treat hypertension in oldest-old.Scand J Prim Health Care. 2018 Mar;36(1):89-98. doi: 10.1080/02813432.2018.1426142. Epub 2018 Jan 25. Scand J Prim Health Care. 2018. PMID: 29366388 Free PMC article.
-
How general practitioners would deprescribe in frail oldest-old with polypharmacy - the LESS study.BMC Fam Pract. 2018 Oct 12;19(1):169. doi: 10.1186/s12875-018-0856-9. BMC Fam Pract. 2018. PMID: 30314468 Free PMC article.
-
Variation in GP decisions on antihypertensive treatment in oldest-old and frail individuals across 29 countries.BMC Geriatr. 2017 Apr 20;17(1):93. doi: 10.1186/s12877-017-0486-4. BMC Geriatr. 2017. PMID: 28427345 Free PMC article.
-
Recommendations for (Discontinuation of) Statin Treatment in Older Adults: Review of Guidelines.J Am Geriatr Soc. 2020 Feb;68(2):417-425. doi: 10.1111/jgs.16219. Epub 2019 Oct 30. J Am Geriatr Soc. 2020. PMID: 31663610 Free PMC article.
-
Aspirin and statin therapy for primary prevention of cardiovascular disease in older adults.Heart. 2022 Jun 24;108(14):1090-1097. doi: 10.1136/heartjnl-2021-320154. Heart. 2022. PMID: 34764212 Free PMC article. Review.
Cited by
-
Barriers and facilitators to deprescribing of cardiovascular medications: a systematic review.BMJ Open. 2022 Dec 22;12(12):e061686. doi: 10.1136/bmjopen-2022-061686. BMJ Open. 2022. PMID: 36549739 Free PMC article.
-
Rationale and design of 'discontinuing statins in multimorbid older adults without cardiovascular disease (STREAM)': study protocol of a randomised non-inferiority clinical trial.BMJ Open. 2025 May 23;15(5):e093833. doi: 10.1136/bmjopen-2024-093833. BMJ Open. 2025. PMID: 40409969 Free PMC article.
-
Exploring how GPs discuss statin deprescribing with older people: a qualitative study.BJGP Open. 2020 May 1;4(1):bjgpopen20X101022. doi: 10.3399/bjgpopen20X101022. Print 2020. BJGP Open. 2020. PMID: 32238392 Free PMC article.
-
Statin Discontinuation and Cardiovascular Events Among Older People in Denmark.JAMA Netw Open. 2021 Dec 1;4(12):e2136802. doi: 10.1001/jamanetworkopen.2021.36802. JAMA Netw Open. 2021. PMID: 34854906 Free PMC article.
-
General practitioners' deprescribing decisions in older adults with polypharmacy: a case vignette study in 31 countries.BMC Geriatr. 2021 Jan 7;21(1):19. doi: 10.1186/s12877-020-01953-6. BMC Geriatr. 2021. PMID: 33413142 Free PMC article.